ANIXA BIOSCIENCES INC Net Income 2006-2021 | ANIX

ANIXA BIOSCIENCES INC net income from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
ANIXA BIOSCIENCES INC Annual Net Income
(Millions of US $)
2021 $-13
2020 $-10
2019 $-12
2018 $-14
2017 $-7
2016 $-5
2015 $-1
2014 $-10
2013 $-10
2012 $-4
2011 $-7
2010 $-5
2009 $-16
2008 $-6
2007 $-5
2006 $-8
2005 $-4
ANIXA BIOSCIENCES INC Quarterly Net Income
(Millions of US $)
2021-10-31 $-4
2021-07-31 $-4
2021-04-30 $-2
2021-01-31 $-2
2020-10-31 $-2
2020-07-31 $-3
2020-04-30 $-3
2020-01-31 $-3
2019-10-31 $-2
2019-07-31 $-2
2019-04-30 $-3
2019-01-31 $-5
2018-10-31 $-5
2018-07-31 $-5
2018-04-30 $-1
2018-01-31 $-2
2017-10-31 $-2
2017-07-31 $-2
2017-04-30 $0
2017-01-31 $-4
2016-10-31 $-1
2016-07-31 $-1
2016-04-30 $-1
2016-01-31 $-2
2015-10-31 $-1
2015-07-31 $-2
2015-04-30 $-2
2015-01-31 $4
2014-10-31 $-3
2014-07-31 $0
2014-04-30 $-3
2014-01-31 $-4
2013-10-31 $-3
2013-07-31 $-3
2013-04-30 $-2
2013-01-31 $-2
2012-10-31 $-2
2012-07-31 $-1
2012-04-30 $-1
2012-01-31 $-1
2011-10-31 $-3
2011-07-31 $-2
2011-04-30 $-1
2011-01-31 $-2
2010-10-31 $-1
2010-07-31 $-1
2010-04-30 $-1
2010-01-31 $-2
2009-10-31 $-13
2009-07-31 $-1
2009-04-30 $-1
2009-01-31 $-1
2008-10-31 $-1
2008-07-31 $-1
2008-04-30 $-2
2008-01-31 $-3
2007-10-31 $-1
2007-07-31 $-1
2007-04-30 $-1
2007-01-31 $-2
2006-10-31 $-2
2006-07-31 $-2
2006-04-30 $-2
2006-01-31 $-1
2005-10-31 $-1
2005-07-31 $-1
2005-04-30 $-1
2005-01-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.093B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.036B 8.91
Bio-Rad Laboratories (BIO.B) United States $17.472B 35.46
QIAGEN (QGEN) Netherlands $11.101B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.210B 0.00
Emergent Biosolutions (EBS) United States $2.527B 9.09
Arcus Biosciences (RCUS) United States $2.184B 0.00
Myovant Sciences (MYOV) United Kingdom $1.260B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.080B 0.00
Zymeworks (ZYME) Canada $0.522B 0.00
SQZ Biotechnologies (SQZ) United States $0.201B 0.00
Ambrx Biopharma (AMAM) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81